Strides Pharma Science Ltd., incorporated in the year 1990, is a Mid Cap company (having a market cap of Rs 7811.73 Crore) operating in Pharmaceuticals sector.
Financials
For the quarter ended 31-12-2020, the company reported a Consolidated sales of Rs 832.02 Crore, up 4.85 % from last quarter Sales of Rs 793.56 Crore and up 13.60 % from last year same quarter Sales of Rs 732.44 Crore Company reported net profit after tax of Rs 62.07 Crore in latest quarter.
Investment Rationale
The brokerage remains positive on STR on the back of its continued focus on broadening product offerings in regulated markets and an improving outlook for the Biotech business under Stelis.
Promoter/FII Holdings
Promoters held 29.7 per cent stake in the company as of Dec 30, 2020, while FIIs held 25.2 per cent, DIIs 16.7 per cent and public and others 28.5 per cent.
